Spots Global Cancer Trial Database for stage ii prostate cancer
Every month we try and update this database with for stage ii prostate cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate | NCT00459407 | Adenocarcinoma ... Stage I Prostat... Stage II Prosta... | defined green t... placebo immunohistochem... immunoenzyme te... laboratory biom... biopsy mass spectromet... high performanc... | 18 Years - | National Cancer Institute (NCI) | |
| Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence | NCT00003645 | Prostate Cancer | Flutamide Leuprolide Acet... | - | M.D. Anderson Cancer Center | |
| Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate | NCT00084864 | Prostate Cancer | calcitriol dexamethasone clinical observ... | 18 Years - 120 Years | Roswell Park Cancer Institute | |
| Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer | NCT03103321 | Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage I Prostat... PSA Level Five ... PSA Level Less ... PSA Level Ten t... | Internet-Based ... Internet-Based ... Best Practice Quality-of-Life... Questionnaire A... Survey Administ... Laboratory Biom... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer | NCT00619515 | Prostate Cancer | questionnaire a... implanted fiduc... stereotactic ra... | - 120 Years | Case Comprehensive Cancer Center | |
| Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer | NCT00830635 | Breast Cancer Depression Long-term Effec... Prostate Cancer Psychosocial Ef... | educational int... informational i... internet-based ... questionnaire a... study of socioe... survey administ... psychosocial as... quality-of-life... | - | University of Colorado, Denver | |
| Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer | NCT00321698 | Prostate Cancer | Intensity-Modul... Docetaxel+IMRT | 18 Years - 100 Years | OHSU Knight Cancer Institute | |
| Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer | NCT00020735 | Prostate Cancer | toremifene conventional su... neoadjuvant the... | 18 Years - 120 Years | University of Pittsburgh | |
| Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer | NCT03963739 | Prostate Adenoc... Stage I Prostat... Stage II Prosta... Stage III Prost... | Interview Questionnaire A... | 18 Years - | Wake Forest University Health Sciences | |
| Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors | NCT03880422 | Cancer Survivor Obesity Overweight Prostate Adenoc... Stage A Prostat... Stage B Prostat... Stage C Prostat... Stage D Prostat... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Dietary Interve... Educational Int... Exercise Interv... Quality-of-Life... Survey Administ... | 18 Years - | Roswell Park Cancer Institute | |
| Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy | NCT00073970 | Prostate Cancer | celecoxib | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Observation or Radical Treatment in Patients With Prostate Cancer | NCT00499174 | Prostate Cancer | conventional su... brachytherapy external beam r... Biopsies | 18 Years - | Canadian Cancer Trials Group | |
| Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer | NCT01023061 | Adenocarcinoma ... Stage II Prosta... Stage III Prost... Stage IV Prosta... | abiraterone ace... prednisone leuprolide acet... laboratory biom... external beam r... goserelin aceta... | 18 Years - | University of Washington | |
| Docetaxel in Treating Patients With Relapsed Prostate Cancer | NCT00482274 | Prostate Cancer | docetaxel | 18 Years - | OHSU Knight Cancer Institute | |
| Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectomy | NCT00888654 | Prostate Cancer | B-Dim Radical Prosate... | 18 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer | NCT00054106 | Prostate Cancer | buserelin custirsen sodiu... flutamide conventional su... neoadjuvant the... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer | NCT00450749 | Adenocarcinoma ... Stage I Prostat... Stage II Prosta... Stage III Prost... | placebo therapeutic con... laboratory biom... lycopene | 18 Years - | National Cancer Institute (NCI) | |
| Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers | NCT00984919 | Prostate Cancer | high performanc... laboratory biom... mass spectromet... | 40 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer | NCT00771017 | Prostate Cancer | GVAX prostate c... bicalutamide goserelin leuprolide acet... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | NCT00897793 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer | venipuncture radiation thera... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer | NCT00651326 | Prostate Cancer | bicalutamide buserelin flutamide goserelin leuprolide acet... neoadjuvant the... quality-of-life... radiation thera... Docetaxel | 18 Years - | Canadian Cancer Trials Group | |
| Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors | NCT03880422 | Cancer Survivor Obesity Overweight Prostate Adenoc... Stage A Prostat... Stage B Prostat... Stage C Prostat... Stage D Prostat... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Dietary Interve... Educational Int... Exercise Interv... Quality-of-Life... Survey Administ... | 18 Years - | Roswell Park Cancer Institute | |
| Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer | NCT00771017 | Prostate Cancer | GVAX prostate c... bicalutamide goserelin leuprolide acet... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer | NCT00400517 | Prostate Cancer | sargramostim thalidomide conventional su... neoadjuvant the... | - 120 Years | The Cleveland Clinic | |
| Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer | NCT00653757 | Prostate Cancer | goserelin aceta... leuprolide acet... image-guided ra... intensity-modul... | 19 Years - | Mayo Clinic | |
| Visually Enhanced Education About Prostate Cancer | NCT02846870 | Stage I Prostat... Stage II Prosta... Stage III Prost... | Visually enhanc... Standard prosta... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery | NCT00977457 | Prostate Cancer | DNA analysis DNA methylation... RNA analysis gene expression... polymerase chai... diagnostic labo... therapeutic con... | 18 Years - | City of Hope Medical Center | |
| Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy | NCT00073970 | Prostate Cancer | celecoxib | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery | NCT00438464 | Adenocarcinoma ... Stage II Prosta... | Finasteride Placebo Prostatectomy Laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer | NCT00005827 | Prostate Cancer | genistein | 40 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer | NCT00002889 | Prostate Cancer | flutamide goserelin leuprolide acet... low-LET photon ... | 30 Years - | Alliance for Clinical Trials in Oncology | |
| Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer | NCT00736645 | Prostate Cancer | selenomethionin... finasteride placebo | 18 Years - | Roswell Park Cancer Institute | |
| Genistein in Treating Patients With Prostate Cancer | NCT01126879 | Adenocarcinoma ... Recurrent Prost... Stage I Prostat... Stage II Prosta... Stage III Prost... | genistein placebo therapeutic con... | 18 Years - | Northwestern University | |
| Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy | NCT00788307 | Prostate Cancer | Ad5-CMV-NIS liothyronine so... reverse transcr... laboratory biom... iodine I 131 | 18 Years - 120 Years | Mayo Clinic | |
| Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer | NCT00062309 | Prostate Cancer | radiation thera... | 18 Years - | Fox Chase Cancer Center | |
| Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer | NCT00243048 | Prostate Cancer | soy protein iso... radiation thera... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Visually Enhanced Education About Prostate Cancer | NCT02846870 | Stage I Prostat... Stage II Prosta... Stage III Prost... | Visually enhanc... Standard prosta... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer | NCT00804245 | Prostate Cancer | needle biopsy PET-CT scans su... | 30 Years - 120 Years | Wake Forest University Health Sciences | |
| Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers | NCT00984919 | Prostate Cancer | high performanc... laboratory biom... mass spectromet... | 40 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer | NCT00900835 | Breast Cancer Colorectal Canc... Fatigue Lung Cancer Pain Prostate Cancer | educational int... questionnaire a... study of socioe... assessment of t... fatigue assessm... quality-of-life... standard follow... | 18 Years - | City of Hope Medical Center | |
| Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer | NCT00714753 | Prostate Cancer | brachytherapy hypofractionate... image-guided ra... intensity-modul... | 18 Years - 120 Years | Mayo Clinic | |
| Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer | NCT00225420 | Prostate Cancer | docetaxel leuprolide acet... radiation thera... | 18 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
| Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery | NCT00458549 | Prostate Cancer | omega-3 fatty a... biopsy | 18 Years - 120 Years | Dana-Farber Cancer Institute | |
| Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy | NCT00058266 | Prostate Cancer | genistein conventional su... | 18 Years - | Northwestern University | |
| Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer | NCT00020735 | Prostate Cancer | toremifene conventional su... neoadjuvant the... | 18 Years - 120 Years | University of Pittsburgh | |
| Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy | NCT00305747 | Prostate Cancer | BR-DIM | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer | NCT00450749 | Adenocarcinoma ... Stage I Prostat... Stage II Prosta... Stage III Prost... | placebo therapeutic con... laboratory biom... lycopene | 18 Years - | National Cancer Institute (NCI) | |
| Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer | NCT03122743 | Hormone-Resista... Recurrent Prost... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... | Biospecimen Col... Laboratory Biom... Questionnaire A... | 18 Years - | Wake Forest University Health Sciences | |
| ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer | NCT00544076 | Prostate Cancer Male Erectile D... Stage I Prostat... Stage II Prosta... | sildenafil citr... alprostadil robotic-assiste... quality-of-life... questionnaire a... | 18 Years - 65 Years | City of Hope Medical Center | |
| Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate | NCT00078923 | Prostate Cancer | soy isoflavones neoadjuvant the... Placebo | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer | NCT00003045 | Prostate Cancer | Hyperthermia XRT | 18 Years - | Dana-Farber Cancer Institute | |
| Selenium in Treating Patients With Prostate Cancer | NCT00752739 | Prostate Cancer | selenium placebo | - 85 Years | University of Arizona | |
| Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery | NCT00977457 | Prostate Cancer | DNA analysis DNA methylation... RNA analysis gene expression... polymerase chai... diagnostic labo... therapeutic con... | 18 Years - | City of Hope Medical Center | |
| Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate | NCT00598858 | Prostate Cancer Adenocarcinoma ... Stage I Prostat... Stage II Prosta... | Docetaxel Prednisone | 18 Years - | University of California, Irvine | |
| Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer | NCT00258466 | Prostate Cancer | radiation thera... | - | Barbara Ann Karmanos Cancer Institute | |
| Family Quality of Life Among Families With a Member Who is a Cancer Patient | NCT00544336 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer Solid Tumor | questionnaire a... survey administ... quality-of-life... | 21 Years - | Vanderbilt-Ingram Cancer Center | |
| Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer | NCT00450229 | Adenocarcinoma ... Prostate Cancer Stage I Prostat... Stage II Prosta... | diindolylmethan... placebo therapeutic con... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer | NCT00054106 | Prostate Cancer | buserelin custirsen sodiu... flutamide conventional su... neoadjuvant the... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy. | NCT00258401 | Cervical Cancer Diarrhea Prostate Cancer Radiation Toxic... Sarcoma | dietary interve... management of t... quality-of-life... | 20 Years - 80 Years | Case Comprehensive Cancer Center | |
| Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer | NCT00830635 | Breast Cancer Depression Long-term Effec... Prostate Cancer Psychosocial Ef... | educational int... informational i... internet-based ... questionnaire a... study of socioe... survey administ... psychosocial as... quality-of-life... | - | University of Colorado, Denver | |
| Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy. | NCT00258401 | Cervical Cancer Diarrhea Prostate Cancer Radiation Toxic... Sarcoma | dietary interve... management of t... quality-of-life... | 20 Years - 80 Years | Case Comprehensive Cancer Center | |
| S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT | NCT00288106 | Prostate Cancer | Follow-up | 55 Years - 120 Years | SWOG Cancer Research Network | |
| Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer | NCT00003329 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer | gene mapping | 0 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer | NCT00003084 | Prostate Cancer | Doxorubicin Hyd... Estramustine ph... Etoposide Ketoconazole Paclitaxel Vinblastine | 18 Years - | M.D. Anderson Cancer Center | |
| Vitamin D in Treating Patients With Prostate Cancer | NCT00524680 | Prostate Cancer | cholecalciferol | 18 Years - 120 Years | Roswell Park Cancer Institute | |
| Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer | NCT00003329 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer | gene mapping | 0 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Vitamin D in Treating Patients With Prostate Cancer | NCT00524680 | Prostate Cancer | cholecalciferol | 18 Years - 120 Years | Roswell Park Cancer Institute | |
| Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer | NCT00653757 | Prostate Cancer | goserelin aceta... leuprolide acet... image-guided ra... intensity-modul... | 19 Years - | Mayo Clinic | |
| Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery | NCT00458549 | Prostate Cancer | omega-3 fatty a... biopsy | 18 Years - 120 Years | Dana-Farber Cancer Institute | |
| Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer | NCT00321698 | Prostate Cancer | Intensity-Modul... Docetaxel+IMRT | 18 Years - 100 Years | OHSU Knight Cancer Institute | |
| GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer | NCT00400517 | Prostate Cancer | sargramostim thalidomide conventional su... neoadjuvant the... | - 120 Years | The Cleveland Clinic | |
| Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer | NCT00005096 | Prostate Cancer | docetaxel | 18 Years - | Dana-Farber Cancer Institute | |
| Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors | NCT03880422 | Cancer Survivor Obesity Overweight Prostate Adenoc... Stage A Prostat... Stage B Prostat... Stage C Prostat... Stage D Prostat... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Dietary Interve... Educational Int... Exercise Interv... Quality-of-Life... Survey Administ... | 18 Years - | Roswell Park Cancer Institute | |
| Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance | NCT00796874 | Prostate Cancer | active surveill... imaging biomark... biopsy dynamic contras... magnetic resona... magnetic resona... | 18 Years - | Roswell Park Cancer Institute | |
| Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer | NCT00005096 | Prostate Cancer | docetaxel | 18 Years - | Dana-Farber Cancer Institute | |
| Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | NCT00246753 | Prostate Cancer | lapatinib ditos... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer | NCT00082732 | Prostate Cancer | behavioral diet... dietary interve... therapeutic die... | - | M.D. Anderson Cancer Center | |
| Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer | NCT00054574 | Prostate Cancer | panitumumab | 18 Years - 120 Years | Jonsson Comprehensive Cancer Center | |
| Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer | NCT01117935 | Adenocarcinoma ... Stage I Prostat... Stage II Prosta... Stage III Prost... Stage IV Prosta... | intensity modul... | 18 Years - | Virginia Commonwealth University | |
| Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer | NCT00003307 | Prostate Cancer Radiation Toxic... | amifostine trih... radiation thera... | 18 Years - | University of Arizona |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
